Close Menu

Trovagene

NEW YORK (GenomeWeb News) – Molecular diagnostics developer Trovagene reported after the close of the market Tuesday that its first-quarter revenues increased to $119,000 from $34,000.

NEW YORK (GenomeWeb News) – Trovagene today said that it has entered into an R&D agreement with PerkinElmer Health Sciences to design an assay for evaluating a patient's risk of developing hepatocellular carcinoma.

NEW YORK (GenomeWeb News) – Trovagene reported after the close of the market Monday that its fourth-quarter revenues increased sharply as its net loss climbed on a change in fair value of derivative instruments related to warrants.

Trovagene this week announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus test.

Caris Life Sciences has named Joachim Schorr to be its chief scientific officer.

Trovagene said this week that it has appointed Mark Elander as chief scientific officer. Erlander will direct the clinical development program for the company's portfolio of transrenal and urine-based molecular diagnostic assays.

Samsung Electronics has been awarded US Patent No. 8,386,191, "Method for quantifying initial concentration of nucleic acid from real-time nucleic acid amplification data."
Kak Namkoong, Jin-tae Kim, Young-sun Lee, and Young-a Kim are named as inventors.

NEW YORK (GenomeWeb News) – Trovagene said in a regulatory filing on Wednesday that it is publicly offering $6.1 million of its common stock.

NEW YORK (GenomeWeb News) – Trovagene this week filed a shelf registration with the US Securities and Exchange Commission for the public offering of up to $150 million in securities from time to time.

Foundation Medicine has appointed Steven Kafka to chief business officer, a newly created position. He joins the company from Aileron Therapeutics, where he served as chief operating officer and chief financial officer.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.